Immune response and reactogenicity of an unadjuvanted intradermally delivered human papillomavirus vaccine using a first generation Nanopatch™ in rhesus macaques: An exploratory, pre-clinical feasibility assessment

The human papillomavirus (HPV) 9-valent, recombinant vaccine (Gardasil™9) helps protect young adults (males and females) against anogenital cancers and genital warts caused by certain HPV genotypes (ref. Gardasil™9 insert). This vaccine is administered intramuscularly (IM). The aim of this study was...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Vaccine X
Main Authors: Meyer, Brian K., Kendall, Mark A.F., Williams, Donna M., Bett, Andrew J., Dubey, Sheri, Gentzel, Renee C., Casimiro, Danilo, Forster, Angus, Corbett, Holly, Crichton, Michael, Baker, S. Ben, Evans, Robert K., Bhambhani, Akhilesh
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Regular paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668242/
https://ncbi.nlm.nih.gov/pubmed/31384745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jvacx.2019.100030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados